OIS@ASCRS 2015

OIS@ASCRS - 2015 Award Winner - Richard Lindstrom, MD

Ophthalmology Lifetime Innovator Award

By Mario Admin | June 10, 2015

Richard L. Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants Participant: Richard Lindstrom, MD Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized…

Read More
Aerie Pharmaceuticals ASCRS 2015

Aerie Pharmaceuticals

By Tom Salemi | June 8, 2015

Rhopressa is a Rho-kinase and norepinephrine transporter inhibitor and lowers episcleral venous pressure, with phase 3 efficacy data expected mid-Q2 2015, and an FDA filing…

Read More
InnFocus ASCRS 2015

InnFocus

By Tom Salemi | June 8, 2015

The MicroShunt has just completed enrollment (n=75) in a pivotal study, and is the only device to be directly compared to trabeculectomy. The device has…

Read More
ForSight VISION5 ASCRS 2015

ForSight VISION5

By Tom Salemi | June 8, 2015

Dedicated to solving compliance problems with ophthalmic medications, ForSight VISION5 has developed Helios, a non-invasive, sustained-release drug delivery system that remains in place for 6…

Read More
Spotlight on Pressure Reduction ASCRS 2015

Spotlight on Pressure Reduction

By Tom Salemi | June 8, 2015

Participants: Kuldev Singh, MD, MPH Dr. Kuldev Singh is Professor of Ophthalmology and Director of the Glaucoma Service at the Stanford University School of Medicine.…

Read More
Spotlight on Presbyopia – Market Overview ASCRS 2015

Spotlight on Presbyopia – Market Overview

By Tom Salemi | June 8, 2015

Participant: Richard Lindstrom, MD Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery. View Full Profile

Read More
Spotlight on Presbyopia ASCRS 2015

Spotlight on Presbyopia

By Tom Salemi | June 8, 2015

Participants: Gilbert H. Kliman, MD Dr. Gil Kliman leads the medical device investment team at InterWest Partners and invests in a broad array of healthcare…

Read More
Spotlight on Drug Delivery ASCRS 2015

Spotlight on Drug Delivery

By Tom Salemi | June 8, 2015

“It’s becoming more like cage fighting than company building.” The Drug Delivery market is increasingly competitive. CEOs from the sector’s leading innovators Ocular Therapeutix, Kala…

Read More
Ocular Therapeutix ASCRS 2015

Ocular Therapeutix

By Tom Salemi | June 8, 2015

The company is evaluating sustained-release injectable anti-VEGF drug depots along with using its proprietary hydrogel platform technology for anterior segment disorders (specifically pain and inflammation).…

Read More
Icon Bioscience ASCRS 2015

Icon Bioscience

By Tom Salemi | June 8, 2015

The company’s proprietary Verisome drug delivery technology is being used as the base for IBI-10090, for post-cataract surgery inflammation. The dexamethasone compound completed a pivotal…

Read More
Kala Therapeutics ASCRS 2015

Kala Therapeutics

By Tom Salemi | June 8, 2015

By penetrating the mucosal barrier in the eye, Kala’s Mucosal Penetrating Products (MPPs) “enhances pharmacokinetics” and can be used to treat both anterior and posterior…

Read More
Envisia Therapeutics ASCRS 2015

Envisia Therapeutics

By Tom Salemi | June 8, 2015

ENV515 is a proprietary, fully biodegradable PRINT (Particle Replication In Non-Wetting Templates) particle formulation of a prostaglandin analog, travoprost, with the potential for sustained intraocular…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.